#Harvoni

Researchers identified this association after looking at real-world data on a large group of German individuals with HIV and hep C.

Such generic drugs could save nations huge sums in the coming years.

Hepatitis C advocate Peter McLoyd transformed his bad times into good ones.

Highlights from research presented at the 52nd International Liver Congress in Amsterdam

Even those who did not qualify for a treatment shorter than 12 weeks did well on the regimen in a real-world study.

Real-world results of eight weeks of the hepatitis C virus treatment Harvoni (ledipasvir/sofosbuvir) are excellent.

Six weeks of Harvoni cured all acute hep C infections in HIV-positive people with HCV viral loads below 7 million in a recent small trial.

HIV-positive singer and activist Sherri Lewis is cured of hepatitis C.

The FDA has approved Gilead Sciences’ Harvoni to treat the virus for genotypes 4, 5 or 6 of hep C, and in those coinfected with HIV.

Here’s what’s in store this year for new hepatitis C therapies, as well as approvals for new uses of existing treatments.

Highlights from presentations at the Annual Meeting of the American Association for the Study of Liver Diseases (AASLD) in San Francisco.

The FDA has approved new indications for Gilead’s Harvoni: to treat hepatitis C in those with genotypes 4Ã¢€“6 of the virus and in those...

Recent trials of the latest hepatitis C virus medications have brought more good news for people coinfected with HCV and HIV.

Gilead has applied to the FDA for approval of the combo tablet of Sovaldi and velpatasvir to treat those with genotypes 1 through 6 of...

The real-world cure rates offered by Sovaldi (sofosbuvir)-based hep C virus regimens have not been as good as those seen in clinical trials